Nephros, Inc. (NEPH)
3.11
-0.05
(-1.58%)
USD |
NASDAQ |
May 01, 16:00
3.10
-0.01
(-0.32%)
After-Hours: 20:00
Nephros Cash from Investing (Quarterly) : 0.00 for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Cerus Corp. | -1.378M |
| Xtant Medical Holdings, Inc. | 4.68M |
| Abbott Laboratories | -20.32B |
| Accuray, Inc. | -5.596M |
| Plus Therapeutics, Inc. | -1.077M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 0.23M |
| Cash from Financing (Quarterly) | -0.001M |
| Free Cash Flow | 1.645M |
| Free Cash Flow Per Share (Quarterly) | 0.0205 |
| Free Cash Flow to Equity (Quarterly) | 0.321M |
| Free Cash Flow to Firm (Quarterly) | 0.23M |
| Free Cash Flow Yield | 4.84% |